Get the latest Science News and Discoveries

Anti-abortion stigma could be holding breast cancer research back. Small studies have suggested medical abortion pill mifepristone could help reduce the risk of breast cancer among particularly vulnerable women but stigma around the pill's use as an abortion medication is holding research back.

Media release From: The Lancet Obstetrics, Gynaecology, & Women’s Health: Stigma prevents medical abortion pill being investigated for breast cancer prevention Small, preclinical studies on breast tissue suggest the pill mifepristone shows promise for reducing the risk of breast cancer, however the use of mifepristone for medical abortion has created barriers for developing it for other purposes, highlights a Viewpoint published in The Lancet Obstetrics, Gynaecology, & Women’s Health journal. Globally, breast cancer is the leading cause of cancer deaths among women.

None

Get the Android app